A birth cohort study in the United Arab Emirates
Official title: The First United Arab Emirates National Representative Birth Cohort Study
Run by United Arab Emirates University · NCT04928898 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to learn more about the health of pregnant Emirati women and their babies by following them through pregnancy and the first two years of the child's life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 60 Years |
| Sex | Women only |
| Enrollment | 250 (estimated) |
| Sponsor | United Arab Emirates University Academic / other |
| Locations | 1 site (Al Ain, Abu Dhabi) |
| Trial ID | NCT04928898 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Emirati women who are between 8 to 12 weeks pregnant with a singleton pregnancy and no major preconception illnesses.
✕Probably not a fit
Patients who are non-Emirati, have multiple pregnancies, or significant chronic illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to recruit 250 pregnant Emirati women in their first trimester to collect comprehensive data on maternal and child health. Participants will undergo 11 visits throughout their pregnancy and the first two years of their child's life, where various factors such as socio-demographics, lifestyle, dietary intake, and psychological state will be assessed. The study seeks to understand the health patterns and outcomes in this population, contributing valuable insights into child and maternal health in the UAE.
Why it matters
Potential benefit: If successful, this study could provide critical data to improve maternal and child health policies and practices in the UAE.
How similar studies have gone: While similar cohort studies have been conducted globally, this specific approach in the UAE is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Emirati Nationality * Within first trimester of pregnancy (between 8 -12 weeks of gestation) * Singleton pregnancy * Absence of major illness preconception (Diabetes mellitus, hypertension, kidney disease, cancer, epilepsy, severe psychiatric illness, and other chronic diseases of infections such as autoimmune disorders, human immunodeficiency virus, and hepatitis). Exclusion Criteria: * Non-Emirati * Unconfirmed viable, intrauterine pregnancy at first obstetric ultrasound during first trimester * Twin or multiple gestation pregnancy and a history of multiple gestations * History of chronic illness (i.e., T2DM, hypertension, etc.) * Previously given birth to babies with malformation, intellectual disability, or inborn errors of metabolism. * Experience of a miscarriage before 28 weeks of gestation * On significant regular medications, including insulin, anti-hypertensive agents, psychotropic medications, anti-epileptic drugs, steroids, immune-suppressive agents, and chemotherapeutic agents.
Where it's running
-
United Arab Emirates University
Al Ain, Abu Dhabi, United Arab Emirates Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.